Document is current
Any future updates will be listed below
-
Authors
Jagne, Isatou
Keeley, Alexander J.
Bojang, Abdoulie
Camara, Bully
Jallow, Edrissa
Senghore, Elina
Oluwalana, Claire
Bah, Saikou Y.
Turner, Claire E.
Sesay, Abdul Karim
D’Alessandro, Umberto
Bottomley, Christian
de Silva, Thushan I.
Roca, Anna
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct01800942 at ClinicalTrials.govDocuments that mention this clinical trial
Impact of intra-partum azithromycin on carriage of group A streptococcus in the Gambia: a posthoc analysis of a double-blind randomized placebo-controlled trial
https://doi.org/10.1186/s12879-022-07080-4
-
Funding
Funding for this research was provided by:
Royal Society & Wellcome Trust (Royal Society & Wellcome Trust Sir Henry Dale Fellow (208765/Z/17/Z))
The University of Sheffield (HEFCE/ODA (155123))
Wellcome Trust (Wellcome Trust Intermediate Clinical Fellowship (110058/Z/15/Z))
MRC UK and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement (MR/J010391/1)
- License Information
-
More Information
Article History
Received: 23 September 2021
Accepted: 11 January 2022
First Online: 29 January 2022
Declarations
:
: The trial was approved by the Joint Gambia Government/MRC Ethics Committee. Written informed consent was obtained from mothers prior to delivery and enrolment in the clinical trial during their pregnancy. The LSHTM Research Ethics Committee provided ethical approval for the secondary data analysis. All methods were carried out in accordance with relevant guidelines and regulations including GCLP and GCP.
: Not applicable.
: All authors declare no competing interests.
